MedPage Today on MSN
Multicomponent test tops PSA for clinically significant prostate cancers
Blood-based biomarker test had similar false-positive rate as PSA, while reducing false ne ...
HealthDay on MSN
Multivariable risk score beneficial for identifying clinically significant prostate cancer
Stockholm3, which combines prostate-specific antigen (PSA), plasma protein biomarkers, polygenic risk, and clinical factors ...
A pioneering blood test detected more than twice as many high-risk prostate cancer cases as current methods, paving the way for more effective screening.
Multiparametric prostate MRI (mpMRI) is being increasingly adopted for work-up of prostate cancer. For patients selected to omit biopsy, we identified factors associated with repeat MRI, eventual ...
In patients with elevated PSA, the urinary MPS2 test had high accuracy for ruling out high-grade prostate cancer requiring biopsy. The urinary 18-gene MyProstateScore 2.0 (MPS2) test can detect ...
Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65-85 living with moderate or greater valvular heart disease (VHD) in the United States, and at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results